Skip to main content

Table 3 Comparison of toxicities between wild type and variant allele groups for VEGFR2 SNPs

From: Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib

Toxicity grade ≥2

N (%*)

VEGFR2 H472Q

VEGFR2 V297I

 

wt allele

var allele

p-value

Wt allele

var allele

p-value

HT

22 (21.4)

26 (38.8)

0.0154

38 (29.0)

12 (30.8)

0.84

HFSR

16 (15.5)

22 (32.8)

0.0136

28 (21.4)

10 (25.6)

0.66

Rash:desquamation

17 (25.0)

13 (28.9)

0.67

23 (27.7)

9 (30.0)

0.82

Diarrhea

14 (20.6)

7 (15.6)

0.62

19 (22.9)

3 (10.0)

0.18

Fatigue

12 (17.7)

6 (13.3)

0.61

14 (16.9)

4 (13.3)

0.78

  1. *% of total patients in that group,p-values are based on Fisher's exact test. wt: wild-type, var: variant.